4DMedical (ASX:4DX) Accounts Receivable : A$1.02 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 4DMedical Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. 4DMedical's accounts receivables for the quarter that ended in Dec. 2023 was A$1.02 Mil.

Accounts receivable can be measured by Days Sales Outstanding. 4DMedical's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 234.97.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. 4DMedical's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was A$-0.01.

4DMedical Accounts Receivable Historical Data

The historical data trend for 4DMedical's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical Accounts Receivable Chart

4DMedical Annual Data

Trend

Jun21

Jun22

Jun23

Accounts Receivable

0.43

1.94

0.58

4DMedical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Receivable	Get a 7-Day Free Trial			0.81	1.94	0.15	0.58	1.02

4DMedical Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

4DMedical Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

4DMedical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.021	/	0.793	*	91
=	234.97

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), 4DMedical's accounts receivable are only considered to be worth 75% of book value:

4DMedical's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(47.879	+	0.75 * 1.021	+	0.5 * 1.112	-	52.601
-	0	-	0)	/	390.884
=	-0.01

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

4DMedical Accounts Receivable Related Terms

Thank you for viewing the detailed overview of 4DMedical's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

4DMedical (ASX:4DX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

FDMDF:USA

Address

700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053

Website

https://www.4dmedical.com

4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines